Astellas Pharma Inc has bought U.S.-based Xyphos Biosciences Inc to expand its immuno-oncology business, a deal worth up to $665 million including potential development milestones and its second acquisition announced this month.
from Reuters: Business News https://ift.tt/2Stqvkj
Thursday, December 26, 2019
Home »
business news
,
latest business news
» Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
Train drivers accept pay deal to end strike action
Aslef said 96.6% of its members who voted backed the deal, marking the end of long-running strikes. from BBC News https://ift.tt/LxCn1G9
0 comments:
Post a Comment